Rusatom Healthcare and Shar Parto Iranian Sign an Agreement to Create a Network of Irradiation Centres in Iran
15 May 2018, Sochi – Rusatom Healthcare, a management company of the Rosatom Group responsible for nuclear medicine and radiation processing research, and Shar Parto Iranian have signed an agreement to create a network of irradiation centres in the Islamic Republic of Iran.
The document was signed by Denis Cherednichenko, CEO of Rusatom Healthcare, and Seyedreza Rafiee, CEO of Shar Parto Iranian.
The project to create a network of radiation processing centres will include establishing a joint engineering company. The facilities, equipped with electron accelerators and gamma ray units, will be used to provide commercial services to sterilize pharmaceutical, cosmetic and medical products, as well as food products.